Graul Ann I
Drug News Perspect. 2003 Jan-Feb;16(1):22-39.
The United States was the most active market for new product launches (22 products, 62.5%) in a year that saw 35 new chemical entities and biological drugs and two diagnostic agents reach their first markets. The most active therapeutic groups were anti-infective, oncolytic and metabolic drugs with five launches for each.
在这一年里,有35种新化学实体药、生物药以及两种诊断试剂首次进入市场,美国是新产品上市最为活跃的市场(22种产品,占62.5%)。最活跃的治疗领域是抗感染药、溶瘤药和代谢药,每种都有5种产品上市。